Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.62 |
| ▸ | VIPR1 | P32241 | 4/20 | 0.62 |
| ▸ | VIPR2 | P41587 | 6/20 | 0.59 |
| ▸ | TFPI | P10646 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 1/20 | 0.54 |
| ▸ | GLP1R | P43220 | 1/20 | 0.54 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31430947 | 0.96 | KISS1R (0.60) | KISS1RVIPR1VIPR2TFPIECE1 | |
| SCHEMBL31430942 | 0.91 | VIPR1 (0.55) | KISS1RVIPR1VIPR2TFPI | |
| SCHEMBL31195744 | 0.90 | KISS1R (0.59) | KISS1RVIPR1VIPR2 | |
| SCHEMBL29479830 | 0.89 | VIPR1 (0.69) | VIPR1VIPR2TFPIECE1GLP1R | |
| SCHEMBL31006347 | 0.88 | TFPI (0.58) | KISS1RVIPR1VIPR2TFPIECE1 | |
| SCHEMBL31047374 | 0.88 | TFPI (0.66) | KISS1RVIPR1VIPR2TFPIECE1 | |
| SCHEMBL29686242 | 0.88 | KISS1R (0.62) | KISS1RVIPR1VIPR2TFPI | |
| SCHEMBL29679607 | 0.88 | TFPI (0.56) | KISS1RVIPR1VIPR2TFPIECE1 | |
| SCHEMBL30432741 | 0.88 | VIPR1 (0.62) | VIPR1VIPR2TFPI | |
| SCHEMBL29489541 | 0.88 | VIPR1 (0.63) | KISS1RVIPR1VIPR2TFPIECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119306845-A | Peptoid compound, preparation method thereof, pharmaceutical composition and application thereof | 杭州禾泰健宇生物科技有限公司 | 2025-01-14 | — | — | CN | disclosed |